• 1
    Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal-cancer mortality. J Natl Cancer Inst. 1992; 84: 1572-1575.
  • 2
    Vijan S, Hwang EW, Hofer TP, et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med. 2001; 111: 593-601.
  • 3
    Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000; 133: 573-584; comment 2000;133:647-649; comment 2001;135:218-219, author reply 219; comment 2001;135:219; comment 2001;135:218, author reply 219.
  • 4
    Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. Am J Gastroenterol. 2009; 104: 739-750.
  • 5
    Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000; 343: 162-168.
  • 6
    Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001; 120: 848-856.
  • 7
    Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329: 1977-1981.
  • 8
    Imperiale TF, Glowinski EA, Lin-Cooper C, et al. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008; 359: 1218-1224; comment 2008;359:1285-1287; comment 2008;359:2611, author reply 2612.
  • 9
    Rim SH, Seeff L, Ahmed F, et al. Colorectal cancer incidence in the United States, 1999-2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115: 1967-1976.
  • 10
    US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2002 Incidence and Mortality Web-Based Report. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2005.
  • 11
    Agrawal S, Bhupinderjit A, Bhutani MS, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005; 100: 515-523; discussion 514.
  • 12
    Rex DK, Rawl SM, Rabeneck L, et al. Colorectal cancer in African Americans. Rev Gastroenterol Disord. 2004; 4: 60-65.
  • 13
    Daguise VG, Burch JB, Horner MJ, et al. Colorectal cancer disparities in South Carolina: descriptive epidemiology, screening, special programs, and future direction. J S C Med Assoc. 2006; 102: 212-220.
  • 14
    Collins JF, Lieberman DA, Durbin TE, et al. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005; 142: 81-85.
  • 15
    American Society of Gastrointestinal Endoscopy. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006; 63: 546-557.
  • 16
    Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005; 142: 86-94.
  • 17
    Thornton JG, Morris AM, Thornton JD, et al. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc. 2007; 99: 723-728.
  • 18
    Blot WJ. The Southern Community Cohort Study: investigating health disparities. Paper presented at: Symposium on Cancer Disparities; March 12-13, 2009; Charleston, SC.
  • 19
    McAlearney AS, Reeves KW, Dickinson SL, et al. Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer. 2008; 112: 391-398.
  • 20
    Xirasagar S, Hurley TG, Sros L, Hebert JR. Quality and safety of screening colonoscopies performed by primary care physicians with standby specialist support. Med Care. 2010; 48: 703-709.
  • 21
    Meissner HI, Yabroff KR, Dodd KW, Leader AE, Ballard-Barbash R, Berrigan D. Are patterns of health behavior associated with cancer screening? Am J Health Promot. 2009; 23: 168-175.
  • 22
    Moy E, Bartman BA. Physician race and care of minority and medically indigent patients. JAMA. 1995; 273: 1515-1520.
  • 23
    Komaromy M, Grumbach K, Drake M, et al. The role of black and Hispanic physicians in providing health care for underserved populations. N Engl J Med. 1996; 334: 1305-1310.
  • 24
    Ostbye T, Yarnall KS, Krause KM, Pollak KL, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005; 3: 209-214.
  • 25
    Crawley LM, Ahn DK, Winkleby MA. Perceived medical discrimination and cancer screening behaviors of racial and ethnic minority adults. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1937-1944.
  • 26
    Gao G, Burke N, Somkin CP, Pasick R. Considering culture in physician-patient communication during colorectal cancer screening. Qual Health Res. 2009; 19: 778-789.
  • 27
    Geiger TM, Miedema BW, Geana MV, Thaler K, Rangnekar NJ, Cameron GT. Improving rates for screening colonoscopy: analysis of the health information national trends survey (HINTS I) data. Surg Endosc. 2008; 22: 527-533.
  • 28
    Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care. 2005; 43: 939-944.
  • 29
    McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol. 2007; 102: 1727-1735.
    Direct Link:
  • 30
    Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006; 30: 313-319.
  • 31
    Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2170-2175.
  • 32
    Lane DS, Messina CR, Cavanagh MF, Chen JJ. A provider intervention to improve colorectal cancer screening in county health centers. Med Care. 2008; 46: S109-S116.
  • 33
    Carcaise-Edinboro P, Bradley CJ. Influence of patient-provider communication on colorectal cancer screening. Med Care. 2008; 46: 738-745.
  • 34
    Nerenz DR. Health care organizations' use of race/ethnicity data to address quality disparities—many of these projects have worked, but there is still much room for improvement. Health Affairs. 2005; 24: 409-416.
  • 35
    Strategies for reducing racial and ethnic disparities in health. Issue Brief No. 5. Washington, DC: Grant Makers in Health; 2000: 1-36.
  • 36
    Gross CP, Andersen MS, Krumholz HM, et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006; 296: 2815-2822.
  • 37
    Seeff LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004; 127: 1661-1669; comment 1841-1844.
  • 38
    Seeff L. South Carolina Survey of Endoscopic Capacity. Final report. Seattle, WA: Battelle, Centers for Public Health Research and Evaluation; 2006.
  • 39
    Fenton JJ, Tancredi DJ, Green P, Franks P, Baldwin LM. Persistent racial and ethnic disparities in up-to-date colorectal cancer testing in Medicare enrollees. J Am Geriatr Soc. 2009; 57: 412-418.
  • 40
    Brounts LR, Lehmann RK, Lesperance KE, et al. Improved rates of colorectal cancer screening in an equal access population. Am J Surg. 2009; 197: 609-613.
  • 41
    Wolf MS, Satterlee M, Calhoun EA, et al. Colorectal cancer screening among the medically underserved. J Health Care Poor Underserved. 2006; 17: 47-54.
  • 42
    Hao Y, Jemal A, Zhang X, Ward EM. Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995-2004 (United States). Cancer Causes Control. 2009; 20: 1855-1863.
  • 43
    Manfredi C, Czaja R, Freels S, et al. Prescribe for health: improving cancer screening in physician practices serving low-income and minority populations. Arch Fam Med. 1998; 7: 329-337.
  • 44
    American Cancer Society Guidelines for the Early Detection of Cancer. Available at: Accessed May 18, 2009.
  • 45
    US Preventive Services Task Force. Screening for colorectal cancer. USPSTF recommendation statement. Ann Intern Med. 2008; 149: 627-637.
  • 46
    Park D, Ryu S, Kim Y, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood test in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010; 105: 2017-2025.
  • 47
    Zimmerman RK, Nowalk MP, Tabbarah M, Grufferman S. Predictors of colorectal cancer screening in diverse primary care practices. BMC Health Serv Res. 2006; 6: 116.
  • 48
    Kronborg O, Fenger C, Olsen J, et al. Randomized study of screening for colorectal cancer with fecal occult blood test. Lancet. 1996; 348: 1467-1471.
  • 49
    Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999; 91: 434-437.
  • 50
    Pabby A, Suneja A, Heeren T, Farraye FA. Flexible sigmoidoscopy for colorectal cancer screening in the elderly. Dig Dis Sci. 2005; 50: 2147-2152.
  • 51
    Papaggrigoriadis S, Arunkumar I, Koreli A, Koreli A, Corbett WA. Evaluation of flexible sigmoidoscopy as an investigation for “left sided” colorectal symptoms. Postgrad Med J. 2004; 80: 104-106.